Crossover: samples of p1 and p2 in different batches? [Bioanalytics]

posted by Ravuri sindhura – India, 2019-09-18 19:16 (326 d 00:30 ago) – Posting: # 20614
Views: 3,733

As per FDA Bioanalytical method validation Guidance for Industry "All study samples from subject should be analysed in a single run, especially for studies designed with repeated measures from individual subjects(eg; crossover or sequential design required for BE studies)".
Can the study samples of same subject in more than single run for cross over design can be analysed i'e analysis of P1 samples and P2 samples can be carried out separately in two different runs? If yes, how it need to be justify to regulatory?


Edit: Category and subject line changed; see also this post #1, #2. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
20,988 posts in 4,375 threads, 1,460 registered users;
online 18 (0 registered, 18 guests [including 14 identified bots]).
Forum time: Sunday 19:47 CEST (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5